Lifecore Biomedical, Inc. LFCR Preferred stock Series C, liquidation preference (in dollars per share)
Preferred stock Series C, liquidation preference (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:TemporaryEquityLiquidationPreferencePerShare.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s preferred stock series c, liquidation preference (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s preferred stock series c, liquidation preference (in dollars per share)?
- Lifecore Biomedical, Inc. (LFCR) reported preferred stock series c, liquidation preference (in dollars per share) of $1,000.00 in Q1 2026.